APPLICATIONS PUBLISHED 11 OCTOBER 2006

Methods and compsns for facilitating metabolic control
The Trustees of Columbia University in the City of New York; Engerbretson, Steven 1708676*

Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin
AstraZeneca 1708679*

Mitratapide oral solution
Janssen Pharmaceutica 1708580*

Cefdinir oral suspension
Abbott Laboratories 1708681*

Formulations for poorly soluble drugs
Bio Dar; Yissum Research Development Company 1708682*

Cefuroxine axetil granule and process for the preparation thereof
Hnami Pharm 1708683*

Drug coating providing high drug loading and methods for providing the same
Alza 1708684*

Effervescent oral opiate dosage forms and methods of administering opiates
Cima Labs 1708685*

Generally linear effervescent fentanyl dosage form and methods of administering
Cima Labs 1708686*

Encapsulation of lipid-based formulations in enteric polymers
Glaxo Group 1708687*

Non-invasive system for detecting skin cancer
CeMines; Arbios Technologies 1708688*

Compsns for treating or preventing obesity and insulin resistance disorders
The President and Fellows of Harvard College 1708689*

Treatment of phenylketonurias with BH4
BioMarin Pharmaceutical 1708690*

Combination of organic compounds
Novartis 1708691*

Dichloroacetate in combination with an inotrope for cardioprotection
The Governors of the University of Alberta 1708692*

Pharmaceutical compsns containing platinum complexes with secondary xanthates and therapeutic uses thereof
Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts: Ruprechts-Karls-Universitaet Heidelburg 1708693*

Compsns and methods for treating contracture
Angiotech International 1708694*

Compsns and method for treatment of steroid/nuclear receptor mediated diseases
National University of Singapore 1708695*

Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
GlaxoSmithKline istrazivacki centar Zagreb 1708696*

Chemical compounds
SmithKline Beecham 1708697*

3-(4-piperidine-1-ylmethylphenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of MCH antagonists (malanine concentrating hormone) for treating eating disorders
Boehringer Ingelheim International 1708698*

Modulators of glucocorticoid receptor, AP-1, and/or NF-K. B activity and use thereof
Bristol-Myers Squibb 1708699*

Metal salts of parecoxib as prodrugs of the COX-2 inhibitor valdecoxib for the treatment of inflammation, pain and/or fever
Pharmacia 1708700*

Modulators of the glucocorticoid receptor, AP-1, and/or NF-KB activity and use thereof
Bristol-Myers Squibb 1708701*

Novel M3 muscarinic acetylcholine receptor antagonists
Glaxo Group 1708702*

Chemokine receptor binding compounds
Anormed 1708703*

4-aryl piperidines
H Lundbeck 1708704*

Pharmaceutical compsn for promoting angiogenesis
Otsuka Pharmaceutical 1708705*

Pharmaceutical compsn comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
Boehringer Ingelheim 1708706*

Pharmaceutical compsn comprising a monoame neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptor antagonist
Boehringer Ingelheim 1708707*

Montelukasr free acid polymorphs
Teva Pharmaceutical Industries 1708708*

Methods of treating acute inflammation in animals with P38 map kinase inhibitors
Pfizer Products 1708709*

Pyrazolo[1,5-A]pyrimidin-7-yl-amine derivatives for use in the treatment of protein kinase dependent diseases
Novartis 1708710*

Compsns useful especially for treatment or prevention of metabolic syndrome
Faron Pharmaceuticals 1708711*

Treatment of malignant gliomas with TGF-beta inhibitors
Scios 1708712*

1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H-quinazolin-2-one derivatives and the respecting 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(D)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine (5-HT) for the treatment of diseases of the central nervous system
F Hoffmann-La Roche 1708713*

Use of substituted pyrimido 5,4-D' pyrimidines in the treatment of diseases of the respiratory tract
Boehringer Ingelheim 1708714*

Use of substituted pteridines for the treatment of diseases of the respiratory tract
Boehringer Ingelheim 1708715*

Oral dieting compsn comprising conjugated linoleic acid and caffeine
Institut Phytoceutic 1708716*

Treatment of allergic rhinitis and asthma
Dunaway, Leslie Joe 1708717*

Triazole derivatives which inhibit vasopressin antagonist activity
Pfizer 1708718*

Aqueous pharmaceutical compsns 2,6-diisopropylphenol (propofol) and their use
Transform Pharmaceuticals 1708719*

Core 2 GLCNAC-T inhibitors
BTG International 1708720*

Myocardial perfusion imaging using adenosine receptor agonists
CV Therapeutics 1708721*

Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
The Regents of the University of California 1708722*

Method for treating hyperphosphataemia using lanthanum hydroxycarbonate
Shire Pharmaceuticals 1708723*

Compsn comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
Pacific Arrow 1708724*

Therapeutical compsns for the treatment of dermatosis comprising an extract of calendula officinalis and hyperium perforatum
Naydenov, Vladimir; Kurdov, Kiril 1708725*

Formulations for treating obesity and associated metabolicc syndrome
Bringwell International 1708726*

Compsn comprising an aqueous extract of red vine leaves and a blood circulation-improving agent for the treatment of chronic venous insufficiencies
Boehringer Ingelheim 1708727*

Compsn comprising an aqueous extract of red vine leaves and a antithrombotic agent for the treatment of chronic venous insufficiencies
Boehringer Ingelheim 1708728*

Compsn comprising an aqueous extract of red vine leaves and a diuretic for the treatment of chronic venous insufficiencies
Boehringer Ingelheim 1708729*

Use of a DG147 protein product for preventing and treating metabolic disorders
DeveloGen 1708730*

Neuroprotective dietary supplement
Ebewe Pharma 1708731*

Synthetic HLA binding peptide analogues and uses thereof
Sloan-Kettering Institute for Cancer Research 1708732*

Use of substances having oxytocin antagonistic properties for the preparation of a medicament for hypertension
Ferring 1708733*

HIV GP41 HR2-derived synthetic peptides, and their use in therapy to inhibit trans-mission of a human immunodeficiency virus
Trimeris 1708735*

Antimicrobial compsn
University of Melbourne 1708735*

Means for stimulation and activation of hair growth by IL-5
Universitaetsklinikum Muenster 1708736*

Use of interleukin-21 for the treatment of autoimmune diseases and allograft rejection
Novo Nordisk 1708737*

A method for reducing serum proinsulin levels in type 2 diabetics
MannKind 1708738*

Neuroprotective complex for treatment of cerebral ischaemia and injury
The Foundation for the LSU Health Sciences Center 1708739*

Protease inhibitors for the treatment of digestive pathologies
Rytek 1708740*

Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria and methods of use thereof
Cerus 1708742*

Passive immunisation against Clostridium difficile disease
Acambis 1708743*

GM1 binding deficient exotoxins for use as immunoadjuvants
Iomai 1708744*

Antibodies for oncogenic strains of HPV and methods of their use
Arbor Vita 1708745*

Recombinant vaccine against Japanese encephalitis virus (JEV) infection and a method thereof
National Institute of Immunology 1708746*

Influenza immunogen and vaccine
Apovia; Vlaams Interuniversitair Instituut voor Biotechnologie 1708748*

Mucosal vaccine adjuvants containing bacterial flegellins as an active component
Industry Foundation of Chonnam National University 1708749*

Targeting of ERB antigens
Mitra Medical 1708750*

Methods of killing tumour cells by targeting internal antigens exposed on apoptotic tumour cells
Vaccinex 1708751*

Polymer-bound antibody cancer therapeutic agent
University of Southern California 1708752*

Combination of serotonin reuptake inhibitors and imidazoline-I SB 2/SB-agonists
Merck Patent 1708754*

Transglutaminase mediated conjugation of peptides
Novo Nordisk 1708755*

Use of human cord blood-derived pluripotent cells for the treatment of disease
Viacell 1708757*

System and method for expression proteomics based on isotope ratio modification
Cedars-Sinai Medical Center 1708758*